Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne S De Groot

Showing results (11-20 of 197) with videos related to

Pageof 20
Sort By:
Medicine and Health, Rhode Island|November 21, 2007
Vaccine renaissance--from basic research to implementationAnne S De Groot, Leonard Moise
Current Opinion in Drug Discovery & Development|June 9, 2007
Prediction of immunogenicity for therapeutic proteins: state of the artAnne S De Groot, Leonard Moise
Expert Review of Vaccines|April 6, 2007
New tools, new approaches and new ideas for vaccine developmentAnne S De Groot, Leonard Moise
Clinical Immunology (Orlando, Fla.)|March 10, 2009
Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeuticsAnne S De Groot, William Martin
Methods (San Diego, Calif.)|November 16, 2004
From genome to vaccine--new immunoinformatics tools for vaccine designAnne S De Groot, Jay A Berzofsky
Trends in Immunology|October 30, 2007
Immunogenicity of protein therapeuticsAnne S De Groot, David W Scott
The AIDS Reader|October 2, 2007
Editorial comment: HIV testing in prisons and jails--providing the carrot with the stickAnne S De Groot, Elizabeth Closson, Christine Devore
Human Vaccines|June 17, 2010
Species neutral correlates of immunogenicity for vaccines and protein therapeutics: fact or science fictionAnne S De Groot, Matthew Baker, Tobias Cohen
Current Opinion in Pharmacology|September 9, 2008
Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlatesAnne S De Groot, Julie McMurry, Lenny Moise
Human Vaccines & Immunotherapeutics|June 5, 2013
Report from the field: Overview of the Sixth Annual Vaccine Renaissance ConferenceDenice Spero, Lauren Levitz, Anne S De Groot
Pageof 20

Showing results (11-20 of 197) with videos related to

Sort By:
Pageof 20
Medicine and Health, Rhode Island|November 21, 2007
Vaccine renaissance--from basic research to implementationAnne S De Groot, Leonard Moise
Current Opinion in Drug Discovery & Development|June 9, 2007
Prediction of immunogenicity for therapeutic proteins: state of the artAnne S De Groot, Leonard Moise
Expert Review of Vaccines|April 6, 2007
New tools, new approaches and new ideas for vaccine developmentAnne S De Groot, Leonard Moise
Clinical Immunology (Orlando, Fla.)|March 10, 2009
Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeuticsAnne S De Groot, William Martin
Methods (San Diego, Calif.)|November 16, 2004
From genome to vaccine--new immunoinformatics tools for vaccine designAnne S De Groot, Jay A Berzofsky
Trends in Immunology|October 30, 2007
Immunogenicity of protein therapeuticsAnne S De Groot, David W Scott
The AIDS Reader|October 2, 2007
Editorial comment: HIV testing in prisons and jails--providing the carrot with the stickAnne S De Groot, Elizabeth Closson, Christine Devore
Human Vaccines|June 17, 2010
Species neutral correlates of immunogenicity for vaccines and protein therapeutics: fact or science fictionAnne S De Groot, Matthew Baker, Tobias Cohen
Current Opinion in Pharmacology|September 9, 2008
Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlatesAnne S De Groot, Julie McMurry, Lenny Moise
Human Vaccines & Immunotherapeutics|June 5, 2013
Report from the field: Overview of the Sixth Annual Vaccine Renaissance ConferenceDenice Spero, Lauren Levitz, Anne S De Groot
Pageof 20